{
  "date": "2025-12-03T20:19:17.886491",
  "test_file": "test_cases_pilot.json",
  "num_cases": 10,
  "aggregate_metrics": {
    "drug_accuracy": 0.1,
    "drug_accuracy_ci_95": [
      0.01787621309507289,
      0.4041500267952385
    ],
    "sl_detection_tpr": 0.8571428571428571,
    "sl_detection_fpr": 0.0,
    "sl_detection_precision": 1.0,
    "sl_detection_recall": 0.8571428571428571,
    "sl_detection_confusion_matrix": {
      "tp": 6,
      "fp": 0,
      "tn": 3,
      "fn": 1
    },
    "mean_essentiality_correlation": 1.0,
    "essentiality_correlation_ci_95": [
      0.0,
      0.0
    ],
    "num_cases_with_correlation": 1,
    "total_cases": 10
  },
  "results": [
    {
      "case_id": "SL_001",
      "ground_truth": {
        "synthetic_lethality_detected": true,
        "known_sl_pairs": [
          "BRCA1+PARP"
        ],
        "effective_drugs": [
          "Olaparib",
          "Niraparib",
          "Rucaparib"
        ],
        "broken_pathways": [
          "HR"
        ],
        "essential_pathways": [
          "PARP"
        ],
        "depmap_essentiality": {
          "BRCA1": 0.92
        },
        "clinical_evidence": {
          "olaparib_fda_approved": true,
          "olaparib_indication": "BRCA-mutated ovarian cancer",
          "response_rate": 0.65
        }
      },
      "prediction": {
        "suggested_therapy": "platinum",
        "essentiality_scores": []
      },
      "metrics": {
        "drug_match": false,
        "sl_detection_tp": true,
        "sl_detection_fp": false,
        "sl_detection_tn": false,
        "sl_detection_fn": false
      }
    },
    {
      "case_id": "SL_002",
      "ground_truth": {
        "synthetic_lethality_detected": true,
        "known_sl_pairs": [
          "BRCA2+PARP"
        ],
        "effective_drugs": [
          "Olaparib",
          "Niraparib"
        ],
        "broken_pathways": [
          "HR"
        ],
        "essential_pathways": [
          "PARP"
        ],
        "depmap_essentiality": {
          "BRCA2": 0.88
        },
        "clinical_evidence": {
          "olaparib_fda_approved": true,
          "response_rate": 0.6
        }
      },
      "prediction": {
        "suggested_therapy": "platinum",
        "essentiality_scores": []
      },
      "metrics": {
        "drug_match": false,
        "sl_detection_tp": true,
        "sl_detection_fp": false,
        "sl_detection_tn": false,
        "sl_detection_fn": false
      }
    },
    {
      "case_id": "SL_003",
      "ground_truth": {
        "synthetic_lethality_detected": true,
        "known_sl_pairs": [
          "MBD4+PARP",
          "TP53+ATR"
        ],
        "effective_drugs": [
          "Olaparib",
          "Ceralasertib"
        ],
        "broken_pathways": [
          "BER",
          "G1/S Checkpoint"
        ],
        "essential_pathways": [
          "HR",
          "ATR/CHK1"
        ],
        "depmap_essentiality": {
          "MBD4": 0.8,
          "TP53": 0.75
        },
        "clinical_evidence": {
          "olaparib_fda_approved": true,
          "ceralasertib_status": "clinical_trials"
        }
      },
      "prediction": {
        "suggested_therapy": "olaparib",
        "essentiality_scores": [
          {
            "gene": "MBD4",
            "score": 0.9
          },
          {
            "gene": "TP53",
            "score": 0.35
          }
        ]
      },
      "metrics": {
        "drug_match": true,
        "sl_detection_tp": true,
        "sl_detection_fp": false,
        "sl_detection_tn": false,
        "sl_detection_fn": false,
        "essentiality_correlation": 1.0
      }
    },
    {
      "case_id": "SL_004",
      "ground_truth": {
        "synthetic_lethality_detected": true,
        "known_sl_pairs": [
          "TP53+ATR"
        ],
        "effective_drugs": [
          "Ceralasertib",
          "Adavosertib"
        ],
        "broken_pathways": [
          "G1/S Checkpoint"
        ],
        "essential_pathways": [
          "ATR/CHK1"
        ],
        "depmap_essentiality": {
          "TP53": 0.7
        },
        "clinical_evidence": {
          "ceralasertib_status": "clinical_trials"
        }
      },
      "prediction": {
        "suggested_therapy": "olaparib",
        "essentiality_scores": [
          {
            "gene": "TP53",
            "score": 0.35
          }
        ]
      },
      "metrics": {
        "drug_match": false,
        "sl_detection_tp": false,
        "sl_detection_fp": false,
        "sl_detection_tn": false,
        "sl_detection_fn": true
      }
    },
    {
      "case_id": "SL_005",
      "ground_truth": {
        "synthetic_lethality_detected": true,
        "known_sl_pairs": [
          "BRCA1+PARP",
          "TP53+ATR"
        ],
        "effective_drugs": [
          "Olaparib",
          "Ceralasertib"
        ],
        "broken_pathways": [
          "HR",
          "G1/S Checkpoint"
        ],
        "essential_pathways": [
          "PARP",
          "ATR/CHK1"
        ],
        "depmap_essentiality": {
          "BRCA1": 0.95,
          "TP53": 0.75
        },
        "clinical_evidence": {
          "olaparib_fda_approved": true,
          "response_rate": 0.7
        }
      },
      "prediction": {
        "suggested_therapy": "platinum",
        "essentiality_scores": []
      },
      "metrics": {
        "drug_match": false,
        "sl_detection_tp": true,
        "sl_detection_fp": false,
        "sl_detection_tn": false,
        "sl_detection_fn": false
      }
    },
    {
      "case_id": "SL_006",
      "ground_truth": {
        "synthetic_lethality_detected": false,
        "known_sl_pairs": [],
        "effective_drugs": [],
        "broken_pathways": [],
        "essential_pathways": [],
        "depmap_essentiality": {
          "OR4F5": 0.1
        },
        "clinical_evidence": {
          "note": "Benign variant, no known SL"
        }
      },
      "prediction": {
        "suggested_therapy": "olaparib",
        "essentiality_scores": [
          {
            "gene": "OR4F5",
            "score": 0.35
          }
        ]
      },
      "metrics": {
        "drug_match": false,
        "sl_detection_tp": false,
        "sl_detection_fp": false,
        "sl_detection_tn": true,
        "sl_detection_fn": false
      }
    },
    {
      "case_id": "SL_007",
      "ground_truth": {
        "synthetic_lethality_detected": false,
        "known_sl_pairs": [],
        "effective_drugs": [],
        "broken_pathways": [],
        "essential_pathways": [],
        "depmap_essentiality": {
          "HLA-A": 0.15
        },
        "clinical_evidence": {
          "note": "Non-essential gene, no SL expected"
        }
      },
      "prediction": {
        "suggested_therapy": "olaparib",
        "essentiality_scores": [
          {
            "gene": "HLA-A",
            "score": 0.35
          }
        ]
      },
      "metrics": {
        "drug_match": false,
        "sl_detection_tp": false,
        "sl_detection_fp": false,
        "sl_detection_tn": true,
        "sl_detection_fn": false
      }
    },
    {
      "case_id": "SL_008",
      "ground_truth": {
        "synthetic_lethality_detected": false,
        "known_sl_pairs": [],
        "effective_drugs": [
          "Trametinib"
        ],
        "broken_pathways": [
          "MAPK"
        ],
        "essential_pathways": [],
        "depmap_essentiality": {
          "KRAS": 0.25
        },
        "clinical_evidence": {
          "note": "KRAS mutation, but no SL relationship"
        }
      },
      "prediction": {
        "suggested_therapy": "olaparib",
        "essentiality_scores": [
          {
            "gene": "KRAS",
            "score": 0.35
          }
        ]
      },
      "metrics": {
        "drug_match": false,
        "sl_detection_tp": false,
        "sl_detection_fp": false,
        "sl_detection_tn": true,
        "sl_detection_fn": false
      }
    },
    {
      "case_id": "SL_009",
      "ground_truth": {
        "synthetic_lethality_detected": true,
        "known_sl_pairs": [
          "BRCA1+PARP"
        ],
        "effective_drugs": [
          "Olaparib",
          "Niraparib"
        ],
        "broken_pathways": [
          "HR"
        ],
        "essential_pathways": [
          "PARP"
        ],
        "depmap_essentiality": {
          "BRCA1": 0.9,
          "PIK3CA": 0.3
        },
        "clinical_evidence": {
          "olaparib_fda_approved": true,
          "note": "BRCA1 SL dominates, PIK3CA secondary"
        }
      },
      "prediction": {
        "suggested_therapy": "platinum",
        "essentiality_scores": []
      },
      "metrics": {
        "drug_match": false,
        "sl_detection_tp": true,
        "sl_detection_fp": false,
        "sl_detection_tn": false,
        "sl_detection_fn": false
      }
    },
    {
      "case_id": "SL_010",
      "ground_truth": {
        "synthetic_lethality_detected": true,
        "known_sl_pairs": [
          "BRCA2+PARP",
          "TP53+ATR"
        ],
        "effective_drugs": [
          "Olaparib",
          "Ceralasertib"
        ],
        "broken_pathways": [
          "HR",
          "G1/S Checkpoint"
        ],
        "essential_pathways": [
          "PARP",
          "ATR/CHK1"
        ],
        "depmap_essentiality": {
          "BRCA2": 0.85,
          "TP53": 0.72
        },
        "clinical_evidence": {
          "olaparib_fda_approved": true,
          "note": "Germline BRCA2 + somatic TP53"
        }
      },
      "prediction": {
        "suggested_therapy": "platinum",
        "essentiality_scores": []
      },
      "metrics": {
        "drug_match": false,
        "sl_detection_tp": true,
        "sl_detection_fp": false,
        "sl_detection_tn": false,
        "sl_detection_fn": false
      }
    }
  ]
}